glp-1 weight regain after stopping receptor agonists | Gustavo Monnerat posted on the topic People who stop weight loss

At the full 12mg maintenance dose, the majority experience some degree of nausea during the first few weeks, though this typically fades substantially by weeks 8-12 at that dose level

It is currently undergoing clinical trials

A new prior authorization is generally not needed for: Regular monthly refills An increase in dose A decrease in dose Your provider must still send a new prescription when your dose changes

Li et al., 2024) and the activation of innate immune cells (kupffer cells) by signals from inflammatory adipokines and endotoxins from the gut (due to gut dysbiosis)

In rodent studies, Reta has been generally well tolerated, with side effects typically limited to those commonly seen with incretin-based therapies, such as transient gastrointestinal symptoms

Anyone using an unregulated product labelled as retatrutide should seek medical advice if they experience severe or persistent symptoms